These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10126489)

  • 41. End-of-life care: an interdisciplinary perspective.
    Viola D; Leven DC; LePere JC
    Am J Hosp Palliat Care; 2009; 26(2):75-8. PubMed ID: 19114604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discounting and health benefits: another perspective.
    Cairns J
    Health Econ; 1992 Apr; 1(1):76-9. PubMed ID: 1342634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In the future will economists determine our therapy? Comments during the European Cardiology Congress].
    Jahrmärker H
    Med Klin (Munich); 1996 Jul; 91(7):472-6. PubMed ID: 8756117
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased capacity may exacerbate rationing problems: with applications to medical care.
    Glazer A; Rothenberg LS
    J Health Econ; 1999 Oct; 18(5):671-80. PubMed ID: 10621371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferences, needs and QALYs.
    Cohen J
    J Med Ethics; 1996 Oct; 22(5):267-72. PubMed ID: 8910777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ramsey pricing and supply-side incentives in physician markets.
    Wedig GJ
    J Health Econ; 1993 Dec; 12(4):365-84. PubMed ID: 10131752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The validity of a visual analogue scale in determining social utility weights for health states.
    Nord E
    Int J Health Plann Manage; 1991; 6(3):234-42. PubMed ID: 10116626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Individual utilities are inconsistent with rationing choices: A partial explanation of why Oregon's cost-effectiveness list failed.
    Ubel PA; Loewenstein G; Scanlon D; Kamlet M
    Med Decis Making; 1996; 16(2):108-16. PubMed ID: 8778528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Making hard choices. Rationing health care services.
    Hicks LL
    J Leg Med; 2011 Jan; 32(1):27-50. PubMed ID: 21391054
    [No Abstract]   [Full Text] [Related]  

  • 51. An approach to allocating limited health resources.
    Borna S; Sundaram S
    J Health Soc Policy; 1999; 11(2):85-94. PubMed ID: 10620862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using seasonal forecasting to improve resource management.
    Hosp Cost Manag Account; 1996 Nov; 8(8):1-8. PubMed ID: 10161426
    [No Abstract]   [Full Text] [Related]  

  • 53. The value of health care: what can we learn from Oregon?
    Street A; Richardson J
    Aust Health Rev; 1992; 15(2):124-34. PubMed ID: 10119044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient flows and optimal health-care resource allocation at the macro-level: a dynamic linear programming approach.
    van Zon AH; Kommer GJ
    Health Care Manag Sci; 1999 May; 2(2):87-96. PubMed ID: 10916605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Health care economic guidance in Germany from the example Morbi-RSA].
    Litmathe J
    Wien Med Wochenschr; 2016 Apr; 166(5-6):182-7. PubMed ID: 26762261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QALYs for resource allocation: probably not and certainly not now.
    Burrows C; Brown K
    Aust J Public Health; 1993 Sep; 17(3):278-86. PubMed ID: 8286505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country.
    Over M; Bertozzi S; Chin J
    Health Policy; 1989; 11(2):169-86. PubMed ID: 10292983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Costs of dying: alternatives to rationing.
    Felder S
    Health Policy; 1997 Feb; 39(2):167-76. PubMed ID: 10165045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Oregon experiment: the role of cost-benefit analysis in the allocation of Medicaid funds.
    Blumstein JF
    Soc Sci Med; 1997 Aug; 45(4):545-54. PubMed ID: 9226780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new approach to the control of distribution of medical imaging equipment in France. The Scientific Committee.
    Frija G; Lhoste JM; Grisoni J
    Acad Radiol; 1996 Apr; 3 Suppl 1():S97-100. PubMed ID: 8796528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.